FMC Corporation (NYSE: FMC) today announced that Pierre Brondeau will transition from his role as executive chairman effective on April 27, 2021, immediately before the 2021 Annual Meeting. He will retire as an employee of the Company coincident with this transition. At the request of the Board of Directors, Mr. Brondeau has agreed to be re-nominated for election as a director of FMC. Assuming his re-election at the 2021 Annual Meeting, the Board intends that Mr. Brondeau will continue to serve as chairman of the Board as a non-employee director after April 27 for the remainder of his elected term.

This change follows the CEO transition from Mr. Brondeau to Mark Douglas that was announced in December 2019 and implemented on June 1, 2020. It is in line with the Board's intention to have a governance structure that includes a non-employee chairman and an independent lead director to ensure strong and effective leadership.

About FMC

FMC Corporation, an agricultural sciences company, provides innovative solutions to growers around the world with a robust product portfolio fueled by a market-driven discovery and development pipeline in crop protection, plant health, and professional pest and turf management. This powerful combination of advanced technologies includes leading insect control products based on Rynaxypyr® and Cyazypyr® active ingredients; Authority®, Boral®, Centium®, Command® and Gamit® branded herbicides; Talstar® and Hero® branded insecticides; and flutriafol-based fungicides. The FMC portfolio also includes biologicals such as Quartzo® and Presence® bionematicides. FMC Corporation employs approximately 6,400 employees around the globe. To learn more, please visit www.fmc.com.